"Retina Eye Surgeons - Most Experienced Retina Team in East Tennessee"

During the past decade, Southeastern Retina Associates conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southeastern Retina Associates" #1 sponsor was "Genentech, Inc." with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Eyetech Pharmaceuticals" with 1 trials sponsored, "NGM Biopharmaceuticals, Inc" with 1 trials sponsored and "National Eye Institute (NEI)" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southeastern Retina Associates" #1 collaborator was "National Eye Institute (NEI)" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "QLT Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Southeastern Retina Associates" are "Geographic Atrophy" (3 trials), "Age Related Macular Degeneration" (1 trials), "Age-Related Macular Degeneration" (1 trials), "Diabetic Macular Edema" (1 trials) and "Diabetic Retinopathy" (1 trials). Many other conditions were trialed in "Southeastern Retina Associates" in a lesser frequency.

Most popular intervention types in "Southeastern Retina Associates" are "Drug" (7 trials), "Other" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lampalizumab" (2 trials), "Aflibercept" (1 trials), "Avastin" (1 trials), "Faricimab" (1 trials) and "Intravitreal Ranibizumab 0.5 mg Injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southeastern Retina Associates" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Southeastern Retina Associates". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Southeastern Retina Associates, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Southeastern Retina Associates, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".